APA (7th ed.) Citation

Raghavan, K., Dedeepiya, V. D., Suryaprakash, V., Rao, K., Ikewaki, N., Sonoda, T., . . . Abraham, S. J. (2022). Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study. Biomedicine & pharmacotherapy, 145, 112243. https://doi.org/10.1016/j.biopha.2021.112243

Chicago Style (17th ed.) Citation

Raghavan, Kadalraja, et al. "Beneficial Effects of Novel Aureobasidium Pullulans Strains Produced Beta-1,3-1,6 Glucans on Interleukin-6 and D-dimer Levels in COVID-19 Patients; Results of a Randomized Multiple-arm Pilot Clinical Study." Biomedicine & Pharmacotherapy 145 (2022): 112243. https://doi.org/10.1016/j.biopha.2021.112243.

MLA (9th ed.) Citation

Raghavan, Kadalraja, et al. "Beneficial Effects of Novel Aureobasidium Pullulans Strains Produced Beta-1,3-1,6 Glucans on Interleukin-6 and D-dimer Levels in COVID-19 Patients; Results of a Randomized Multiple-arm Pilot Clinical Study." Biomedicine & Pharmacotherapy, vol. 145, 2022, p. 112243, https://doi.org/10.1016/j.biopha.2021.112243.